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To evaluate the physiological and symptom determinants of exercise performance (EP) as measured by a 6-min
walking test (6MWD), Wattmax, and peak oxygen consumption ( _VO2 ml/min/kg), 105 patients with chronic airway
obstruction (CAO) [50 chronic obstructive pulmonary disease (COPD): 44 men, aged 637 years, forced
expiratory volume in 1 sec (FEV1) forced vital capacity (FVC)
71% 5413; and 55 asthmatic: 23 men, aged 5510
years, FEV1 FVC
71% 6510] underwent evaluation of 6MWD, symptom limited cyclo-ergometer exercise test,
spirometry, respiratory muscle function, arterial blood gases and sensation of dyspnoea [using the Borg scale,
Visual Analogue Scale (VAS) and Baseline Dyspnoea Index (BDI)].
A hierarchical method of analysis identified the residual volume (RV), total lung capacity (TLC)71 ratio, BDI
and the patient’s age as the strongest and most consistent correlates of EP (r2=014–021). The correlation between
EP and its various determinants was not influenced by diagnosis. The relationship between breathlessness and EP
was dierent between men and women: at any given level of exercise, women were more breathless than men. In
multivariate analyses that contained both RV TLC71 and BDI, the RV TLC71 ratio was the strongest correlate of
EP, although the BDI remained a significant covariate. Overall, age was the major determinant of EP but inclusion
of the RV TLC71 ratio and the BDI into the model explained a further 9–15% of the variance in EP. These three
covariates together explained 26–34% of the variance between patients.
We conclude that in stable CAO patients, the prediction of exercise capacity by anthropometric, demographic,
clinical and physiological variables is likely to be low. Age, pulmonary hyperinflation and dyspnoea are the
strongest and most consistent correlates of impaired exercise performance. Airways obstruction, measured during
expiration using FEV1, does not appear to be a predictor of physiological impairment. These results underline the
importance of performing exercise evaluation in CAO patients.
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Exercise limitation caused by chronic airway obstruction
(CAO) is known to be related to dierent factors (1),
although a number of these may be inter-related. Factor
analysis of data obtained in patients with chronic ob-
structive pulmonary disease (COPD) showed that related
variables may be grouped into a relatively small number of
domains, e.g. exercise performance, lung function and
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objective measures (lung volumes and respiratory muscle
force) and subjective measures (dyspnoea and exercise
tolerance) are quantities which independently characterize
the condition of these patients. The independence of
outcome measures in patients with stable bronchial asthma
as compared to COPD has not been defined, and few
studies have analysed critically the potential determinants
of exercise performance (EP) in patients with COPD and
asthma.
The present study was therefore designed to provide a
structured and hierarchical analysis of the determinants of
EP in patients with chronic CAO. Evidence of independent
factors would support the validity of routine multifactorial
assessment in these patients. Three groups of factors or# 2000 HARCOURT PUBLISHERS LTD
EXERCISE PERFORMANCE IN CAO 257domains were selected: 1. demographics and anthropo-
morphics; 2. lung and respiratory muscle function; 3.
dyspnoea. A number of variables within each of these
domains were measured and related to three measures of
EP: (i) peak oxygen consumption (peak _VO2); (ii) maximum
load (in W) obtained in a symptom-limited exercise test; (iii)
6-min walking distance (6MWD). A hierarchical method of
analysis was used in which the factor in each domain that
most strongly and consistently correlated with EP was
identified. These factors were then used in multivariate
regressions to assess their individual contributions to EP.
Methods
The Ethical Committee of the Medical Centre of Gussago,
‘‘Salvatore Maugeri’’ Foundation, approved the study,
which was conducted according to the declaration of
Helsinki. Patients gave informed consent to participate.
PATIENTS
One hundred and five patients with stable CAO (50 COPD;
55 asthmatic) were recruited into the study. The diagnosis
of COPD was made according to the American Thoracic
Society (ATS) guidelines (5). COPD patients were current
smokers or had a history of smoking (420 pack-years).
Asthma was characterized by dyspnoea with wheezing,
variable airflow limitation with reversible obstruction
[change in forced expiratory volume in 1 sec (DFEV1)
post-bronchodilator: meanSD: 2810%; range: 12–55%],
and bronchial hyper-responsiveness (6), in the absence
of smoking history. All the study patients were known
to our institution as they regularly attended the
outpatient clinic. At the time of recruitment into the study,
all patients were in a stable condition, as assessed by
stability in blood gas values, and had been free from
exacerbation in the previous 4 weeks. Patients with other
organ failure, cancer or an inability to co-operate were
excluded from the study. All asthmatic patients were
receiving inhaled steroids and bronchodilators, whereas
all COPD patients were receiving regular treatment with
inhaled bronchodilators. No COPD patient was receiving
regular treatment with an inhaled or oral steroid. No
change in the patients’ routine therapy was made in the
week before inclusion into the study.
MEASUREMENTS
Lung volume and forced vital capacity (FVC) were
measured using a constant volume body plethysmograph
(Medical Graphic Corp, St. Paul, MN, U.S.A.) according
to the standard procedure. Predicted values according to
Quanjer were used for assessment (7). Arterial blood was
sampled at the radial artery when the patients, in a sitting
position, had been breathing room air for at least 1 h.
Arterial oxygen tension (Pa,O2), arterial carbon dioxide
tension (Pa,CO2) and pH were measured using an auto-
mated analyser (ABL 300, Radiometer, Copenhagen,Denmark). The respiratory muscle strength was assessed
by measuring the maximal inspiratory and expiratory
pressures (MIP and MEP, respectively) at the levels of
functional residual capacity (FRC) and total lung capacity
(TLC) respectively, according to Black and Hyatt (8) and
using a respiratory module system (Medical Graphic Corp,
St. Paul, MN, U.S.A.). Predicted values according to
Bruschi et al. (9) were used. Each patient performed a
minimum of five manoeuvres with an interval of at least
1 min between eorts until two acceptable values which did
not dier from each other by more than 5% were obtained.
The best value was recorded.
Symptom-limited incremental exercise tests were per-
formed on an electrically braked cycloergometer (Ergome-
tris 800S, Sensormedics, Yorba Linda, CA, U.S.A.) using
the standard 1-min incremental cycle exercise protocol.
Functional and metabolic data were determined at rest and
during exercise by means of a computerized system (2900Z,
Sensormedics, Yorba Linda, CA, U.S.A.): mixed-expired
gas data, minute ventilation ( _VE), breathing pattern,
oxygen consumption ( _VO2), carbon dioxide production
( _VCO2) and the respiratory exchange ratio were continu-
ously monitored as average values at 20 sec intervals.
Electrocardiographic activity was monitored continuously
and systemic arterial blood pressure was registered every 3
min using a sphygmomanometer. After stabilization and a
2-min period of unloaded pedalling at 60 cycles min71, the
load was increased by 10 W per minute. The patients were
strongly encouraged to cycle to the point of intolerable
breathlessness, discomfort or exhaustion; until the maximal
heart rate was achieved; until an abnormal electrocardio-
gram was noted (symptom-limited exercise test); or until the
patient wanted to stop. At rest and at 10 W intervals,
patients were asked to quantify their perceived breath-
lessness and leg eort by pointing at a number or a phrase
on a 10-point modified Borg scale set in large type on a
sheet in front of them (10). Exercise capacity was also
evaluated by means of the 6MWD (11). Verbal encourage-
ment was given at definite intervals during the test. Three
practice tests were performed on 2 consecutive days and the
highest value achieved was recorded. All measurements
were performed and recorded under the supervision of a
nurse not involved in the study.
Chronic exertional dyspnoea was assessed by the Baseline
Dyspnoea Index (BDI). The BDI is a multidimensional
instrument for measuring dyspnoea based on three compo-
nents: magnitude of task, magnitude of eort and functional
impairment (12). Each component can score from 0 (severe
impairment) to 4 (not impaired) on the index. A baseline
focal score was obtained, which was the sum of the three
components, and ranged from 0 to 12: the lower the rating,
the worse the dyspnoea. An Italian translation of
the BDI was used (13,14). Subjective rating of dyspnoea
was also, performed using a visual analogue scale (VAS) (15).
STATISTICAL ANALYSIS
Simple regression analysis was used to correlate EP with
both physiological and symptom parameters. In the
258 K. FOGLIO ET AL.univariate analysis, a P5001 significance level was used,
while in the multivariate analysis, where specific hypotheses
were tested, a P5005 level of significance was used. To
verify the mutual influence of dierent variables as
determinants of EP, a series of analyses of variance
(ANOVAs) with types I and III sums of squares was
performed. In the type I sums of squares method, each term
is corrected only for the terms that precede it in the model
table. Thus, the sums of squares add up to the total sum of
squares. The type III sums of squares methods calculates
the sum of squares as the sum of squares adjusted for any
eect that does not contain that particular term.
Results
Anthropometric, demographic and functional data for all
the patients according to the diagnosis are given in Table 1.
Compared to asthmatics, COPD patients were older,
suered from more severe obstruction (FEV1) and hyperin-
flation (thoracic gas volume; TGV), were more dyspnoeic
(BDI) and had lower exercise tolerance (peak _VO2).
The potential determinants of exercise performance were
divided into three groups of variables: demographics/
anthropometrics; physiological; and breathlessness. Exer-
cise performance was measured as the number of meters
walked along a corridor during the 6MWD, the maximum
load achieved during cycle ergometry (Wmax), and _VO2 at peak
exercise during cycle ergometry (peak _VO2, ml min
71 kg71).
DEMOGRAPHY AND
ANTHROPOMETRICITY
Age was significantly correlated with all measures of
exercise performance: 6MWD (r=036); Wmax (r=041);TABLE 1. Demographic, anthropometric, functional, exercise a
(meansSD)
Total
Sex (M,F) 67,38
Age (years) 5910
BMI (kg m72) 264
FVC (%pred) 7821
FEV1 (%pred) 5720
RV TLC71 (%) 4610
MIP (%pred) 6320
MEP (%pred) 7423
6 MWD (m) 46761
Max. load (W) 8225
_VO2 max (l min
71) 125032
Peak _VO2 (ml min
71kg71) 18351
PaO2 (kPa) 10212
(mm Hg) 779
PaCO2 (kPa) 5205
(mmHg) 394
See text for abbreviationspeak _VO2 (r=044) (P5001). The peak exercise Wmax was
dierent between men and women (P5001), but 6MWD
and peak _VO2 were not. Body mass index (BMI) was not
correlated with any of the exercise measures.
LUNG FUNCTION
Of the measured variables, patho-physiological only FVC
(%pred), FEV1 (%pred), slow vital capacity (SVC)
(%pred), RV TLC71 (%), maximum inspiratory pressure
(MIP) and PaO2 showed a significant correlation with at
least one of the exercise performance indexes (Table 2). The
RV TLC71 ratio was the strongest and most consistent
correlate of impaired EP (r2=014–021), whereas FEV1
(%pred), SVC (%pred) and PaO2 correlated only with one
exercise index each. None of these correlations was
influenced by either diagnosis or gender.
SENSATION
Breathlessness, measured using the VAS and the BDI,
correlated with all three measures of EP (Table 3), but the
proportion of shared variance with exercise was greatest
when breathlessness was measured using the BDI. Borg
scores for dyspnoea and leg eort, whether at rest or at the
maximum work rate, did not correlate with any of the
measures of EP (r2=00–002, all P40.1). Diagnosis had
no eect on either the slope or the intercept of the
regressions between exercise and scores for VAS and
BDI. Gender influenced the intercept of the relationship
between breathlessness and EP in the following regressions:
6MWD vs. VAS (P=0005); 6MWD vs. BDI (P=0016); W
vs. VAS (P=0003); and W vs. BDI (P=001). In each case
this dierence indicated that for a given level of dyspnoea,
women achieved a lower level of exercise than men, i.e.nd symptomatic characteristics of population in the study
Asthma COPD
23,32 44, 6
5510** 638**
2716 2612
8620 6817
6517** 4819**
429 519
6419 6220
7022 7922
47462 46059
8628 7720
133035* 114023*
19554 16742
10513 1012
7810 759
505 5205
384 394
TABLE 2. Functional indexes which correlated with at least one exercise performance parameter at P5001
Peak _VO2, (ml min
71kg71) Wmax 6MWD (m)
n=68 n=103 n=105
r2 P r2 P r2 P
FVC 011 0007 007 001 003 n.s.
FEV1 005 n.s. 008 0003 002 n.s.
SVC 007 001 001 n.s. 0006 n.s.
RV TLC71 014 0002 021 500001 017 500001
MIP 005 n.s. 010 0001 008 0004
PaO2 006 n.s 008 0008 004 n.s.
See text for abbreviations.
n.s., not significant (P>001).
TABLE 3. Correlations between dyspnoea indexes and exercise performance parameters
Peak _VO2 min
71 kg71 Wmax 6MWD (m)
r2 P r2 P r2 P
VAS 011 0006 0096 0002 006 0001
BDI 0096 001 017 500001 012 00003
See text for abbreviations.
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vs. exercise relationship. The slope of the breathlessness vs.
exercise relationship was not influenced by gender.
INFLUENCE OF AGE ON LUNG FUNCTION
Age explained most of the variance in the correlations
between lung function and EP (Table 4). The only
exception was the eect of RV TLC71 ratio on Wmax and
the 6MWD.
INFLUENCE OF AGE ON BREATHLESSNESS
Age was the major covariate in the relationship between
breathlessness and EP (Table 5). Age accounted for nearly
all of the eect of VAS scores on EP. However, the eect of
the BDI on Wmax and the 6MWD was still significant at
P50.001, despite the eect of age.
DYSPNOEA SCORES VS. EXERCISE
PERFORMANCE
To test which dyspnoea score was the strongest correlate of
EP, a series of multiple regression analysis was carried out
(Table 6). VAS and the BDI were used as covariates, withEP as the dependent variable. The BDI was the dominant
covariate for regressions against all measures of EP. Even
when VAS was used as the first covariate in a stepwise
regression, the BDI became the dominant correlate when it
was added to the regression.
PHYSIOLOGY AND BREATHLESSNESS VS.
EXERCISE PERFORMANCE
The preceding analyses had shown that the RV TLC71
ratio, the BDI and age all appeared to be consistently
correlated with EP. To test whether these eects were
independent, two multivariate models were used. In the
first, the RV TLC71 ratio and the BDI were compared with
EP. The RV TLC71 ratio was the strongest correlate (Table
7), but the BDI was also a significant covariate in those
models which used Wmax and the 6MWD as dependent
variables. Age was then added to these models to estimate
the additional contribution attributable to this factor. In
each model, age was an additional significant covariate
(P5005). Overall, 26–34% of the total variance in exercise
performance was attributable to these representative
demographic, lung function and dyspnoea variables. For
comparison, the correlation for a simple linear regression
between EP and age is included in Table 7. It is clear that,
whilst age is a highly significant determinant of EP, the RV
TABLE 4. Influence of age on lung function—exercise performance relationship. ANOVA with type III sums of squares
Peak _VO2 (ml min
71kg71) Wmax 6MWD (m)
F P F P F P
FVC 51 0028 26 01 06 04
Age 123 00008 150 00002 132 00004
FEV1 23 014 56 002 16 04
Age 136 00005 160 00001 142 00003
SVC 31 008 01 07 0002 10
Age 128 00007 185 00001 152 00002
RV TLC71 18 018 103 00018 79 0006
Age 63 0014 42 042 33 007
MIP 42 0045 42 005 85 0004
Age 157 00002 110 00015 156 00001
PaO2 08 04 27 01 12 03
Age 111 00015 147 00002 122 00007
Level of statistical significance, P5001.
See text for abbreviations.
TABLE 5. Influence of age on the breathlessness–exercise
performance relationships
F P-value
Peak _VO2
VAS 42 005
Age 110 00015
BDI 51 0027
Age 131 00006
Wmax
VAS 56 0019
Age 149 00002
BDI 201 00001
Age 206 00001
6MWD
VAS 31 008
Age 125 00006
BDI 131 00005
Age 152 00002
Level of statistical significance, P5001.
TABLE 6. Multivariate analysis (ANOVA with types I and
III sums of squares): dyspnoea scores vs. exercise perfor-
mance
P-value
Type I SS Type III SS
Peak _VO2 (ml mm
71kg71)
VAS 0047 0017
BDI 0028 0028
Wmax
VAS 0002 0018
BDI 00003 00003
6MWD (m)
VAS n.s. n.s.
BDI 00002 00002
Level of statistical significance, P5005; n.s., not signifi-
cant.
260 K. FOGLIO ET AL.TLC71 ratio and BDI together explain a further 9–15% of
the variance in EP.
Discussion
This study the value of prediction of exercise capacity of
anthropometric, demographic, clinical and physiological
variables was low in stable CAO patients. The strongest
and most consistent correlates of impaired exercise
performance in CAO patients were pulmonary hyperinfla-tion as measured by the RV TLC71 ratio, dyspnoea as
measured by the BDI and the patient’s age. This conclusion
was reached using a hierarchical method of analysis that
allowed the identification of the dominant determinants of
EP in each of three domains, (i) demographic and
anthropometric; (ii) lung and respiratory muscle function
and (iii) dyspnoea and leg eort.
We used three dierent measures of EP, two of which
were derived from the same incremental cycle ergometer
test and the third which was a 6-min walk test. The pattern
of correlation between the EP and its determinants was
consistent, regardless of the EP measure used. Whilst this
TABLE 7. Multivariate analysis (ANOVA with type III sums of squares) to test the influence of lung hyperinflation, dyspnoea
and age on exercise, the predominant factor between ‘RV TLC71 and BDI’, and ‘RV TLC71, BDI, and age’ in correlating
with exercise performance
Peak _VO2 6MWD
(ml min71 kg71) Wmax (m)
F P F P F P
RV TLC71 66 0013 189 00001 146 00002
BDI 36 006 128 00005 78 0006
r2=018 r2=030 r2=023
RV TLC71 72 04 52 0025 41 0047
BDI 40 005 149 00002 90 0003
Age 66 0012 62 0014 46 0035
r2=026 r2=034 r2=026
Age 154 00002 171 00001 103 0002
r2=017 r2=019 r2=012
Level of statistical significance. P5005.
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parameters, it is surprising that the 6MWD showed a
similar pattern as this is a self-paced rather than a
symptom-limited incremental test.
Age correlated with all measures of EP and accounted for
most of the variance in the correlations between lung
function and EP, except the eect of the RV TLC71 ratio.
In this study, as in previous investigations (16,17),
spirometry measures were found to correlate with EP, but
the eect of these was removed once age was added to the
regression model. Patients with COPD demonstrate widely
variable exercise capacities. The FEV1 has been considered
to be a good marker of the link between lung function and
EP, based on reports of good correlations (r 078)
between FEV1 and peak _VO2 (17). However, it has been
shown that when these variables are normalized (FEV1
%pred vs. _VO2max % pred) (16), the correlation coecient
may be quite low (r=049) indicating that disease-related
changes in lung function as reflected by FEV1 (% pred)
account for less than 25% of the variability in peak _VO2.
Therefore, the FEV1 is not a good predictor of EP. Bauerle
et al. (18) have shown that, after normalizing to remove
eects of age, sex and body size, the ability to exceed
maximum expiratory flow, susceptibility to develop dy-
namic hyperinflation and ventilatory response to exercise
correlate significantly with peak _VO2. These three factors
were all better correlates of EP than the FEV1. In the
present study, only the RV TLC71 ratio remained a
significant physiological correlate of EP once age was
included in the model, although MIP was also significant in
a regression against the 6MWD. Other reported physiolo-
gical determinants of exercise in COPD include ventilatory
response to exercise (18). In another study, it was found
that peak _VO2 was best predicted using a stepwise
regression which included the carbon monoxide diusing
capacity, maximum voluntary ventilation, resting minuteventilation, and peak exercise ratio of dead space to tidal
volume (17). In our study, MIP correlated with EP, but this
was not the strongest correlation. Dillard et al. (20)
demonstrated a very strong correlation between peak _VO2
and MIP, which led them to conclude that inspiratory
muscle strength may be an important determinant of
exercise capacity in COPD. However, the study by Carlson
et al. (17) did not confirm this.
In terms of breathlessness, the Borg score for dyspnoea,
whether at rest or at the maximum work rate, correlated
with none of the measures of EP. Of the other dyspnoea
measures, the BDI was the dominant correlate, even when
the VAS was added first to a stepwise regression which
included both measures. It is noteworthy that the BDI (an
indirect measure of breathlessness that quantifies its eect
on daily physical activity) proved to be a better measure of
performance during an exercise test than either of the direct
measurements of dyspnoea taken during the test.
Multivariate analysis showed that dyspnoea in daily life
and lung over-inflation were both significant covariates of
EP, whether measured in a symptom-limited peak perfor-
mance test or a self-paced test. Whilst age was the best
overall correlate of EP, with a shared variance of 15%, the
addition of the BDI and the RV TLC71 ratio to the model
explained a further 15% of the variance in exercise
performance between subjects. Despite the use of these
three significant predictors, a large proportion of the
variance in EP remained unexplained by in our study.
Although in our study Borg scores for leg eort, whether
at rest or at the maximum work rate, did not correlate with
any of the measures of EP, one notable omission from the
panel of measures we used was peripheral muscle strength.
In a stepwise multiple regression analysis on patients
suering from COPD of severity similar to our patients
(FEV1 %pred, 4319) Gosselink et al. (25) showed that
quadriceps strength, was a significant correlate of exercise
262 K. FOGLIO ET AL.capacity and 6MWD, independent of the impairment in
respiratory function. Killian et al. (27) observed that
symptoms of leg fatigue and dyspnoea frequently limited
exercise performance in both COPD and normal subjects,
and Hamilton et al. (28) showed that both excessive leg
eort and excessive dyspnoea were experienced during
exercise in patients with cardiorespiratory impairment
compared with normal individuals. In contrast to our
study, they found a significant relationship between work
capacity and symptom intensity at 50% of work capacity.
More recently, Bernard et al. (29) have confirmed that
peripheral muscle weakness is commonly found in COPD
patients. They found that the strength of three muscle
groups and the right thigh muscle cross-sectional area as
evaluated by computed tomography were reduced in
COPD, but that their ratio was not dierent from that in
healthy controls, suggesting that weakness in COPD is due
to muscle atrophy (30). In that study, quadriceps strength
correlated positively with the FEV1 (%pred).
In the present study, the relationship between EP and its
various determinants was not influenced by type of disease.
The RV TLC71 ratio was the best physiological correlate
of EP, and this relationship was maintained regardless of
the nature of the underlying disease. This appears to be in
contrast to previous observations on dierences in the
relationship between subjective dyspnoea ratings and
objective lung function measures in asthma and COPD
(30). Results similar to ours have previously been reported
only in COPD (17,19,20). Our findings show that in both
asthma and COPD, lung over-inflation appears to be a
more powerful determinant of EP than obstruction to the
expiratory airflow. The relationship between breathlessness
and EP was significantly dierent between men and women.
This dierence was due to an intercept shift in the
relationship curve i.e. at any given level of exercise women
were more breathless than men. This dierence was not
influenced by the level of exercise as the slope of the
relationship was not dierent.
In summary, in stable CAO patients the prediction of
exercise capacity by anthropometric, demographic, clinical
and physiological variables is likely to be low. Age,
pulmonary hyperinflation and dyspnoea are the strongest
and most consistent correlates of impaired exercise
performance. Airways obstruction, measured during ex-
piration using FEV1, does not appear to be a predictor of
physiological impairment. These results underline the
importance of performing exercise evaluation in CAO
patients and of measures aimed at bronchodilation (drug
therapy) and reduction in lung volumes (drugs and/or
surgery) to reduce dyspnoea. Reduction of age at present
appears impossible.
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